Ledger.Open graph →
SEC Form D · filed December 22, 2025

Aeovian Pharmaceuticals, Inc

Offering
$55.0M
Sold
$55.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Berkeley, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Nils J. Regge · Berkeley, CADirectorJustin J. Gover · Berkeley, CADirectorAlex M. Page · New York, NYDirectorJohn J. Kincaid · Berkeley, CAExecRichard J. Gaster · Berkeley, CADirectorRichard J. Gaster · Berkeley, CADirectorDavis J. Ryman · Berkeley, CAExecYoussef J. Bennani · Berkeley, CADirectorAllison J. Hulme · Berkeley, CAExec · DirectorWilliam J. Greene · Berkeley, CADirectorThemasap J. Khan · Berkeley, CADirectorMicah J. Zajic · Berkeley, CAExecRima C. Simson · New York, NYExecWilliam J. Greene · Berkeley, CADirectorScott Carson · Park City, UTDirectorAllison J. Hulme · Berkeley, CAExec · DirectorYoussef J. Bennani · Berkeley, CADirectorThemasap J. Khan · Berkeley, CADirectorMicah J. Zajic · Berkeley, CAExecLars J. Ekman · Berkeley, CADirectorJohn J. Kincaid · Berkeley, CAExecMark Attanasio · Culver City, CADirectorRob Mlenek · Bloomington, MNExecJustin J. Gover · Berkeley, CADirectorLars J. Ekman · Berkeley, CADirectorDavis J. Ryman · Berkeley, CAExecNils J. Regge · Berkeley, CADirectorDavid Licata · Culver City, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗